G01N 2500/20
Cell-free systems
Official title: cell-free systems
G01N2500/20 (Cell-free systems) appears on 475 US grants and 845 published applications in this corpus.
Search patents in G01N- Granted patents
- 475
- Published applications
- 845
- Assignees
- 464
- Inventors
- 1,753
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 6 | 0 |
| 1998 | 10 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 15 | 2 |
| 2002 | 17 | 54 |
| 2003 | 19 | 74 |
| 2004 | 10 | 40 |
| 2005 | 17 | 41 |
| 2006 | 18 | 33 |
| 2007 | 13 | 20 |
| 2008 | 18 | 23 |
| 2009 | 9 | 14 |
| 2010 | 16 | 14 |
| 2011 | 12 | 20 |
| 2012 | 11 | 21 |
| 2013 | 11 | 27 |
| 2014 | 16 | 26 |
| 2015 | 16 | 79 |
| 2016 | 17 | 73 |
| 2017 | 31 | 69 |
| 2018 | 35 | 38 |
| 2019 | 34 | 32 |
| 2020 | 21 | 29 |
| 2021 | 15 | 22 |
| 2022 | 16 | 24 |
| 2023 | 18 | 15 |
| 2024 | 5 | 26 |
| 2025 | 17 | 16 |
| 2026 | 8 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compounds for inhibition of inflammation25 Aug 2026US 12,714,716 B2Children's Medical Center Corporation
- Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins16 Jun 2026US 12,655,183 B2Guangzhou Inno-Enmai Biomedical Technology Co., Ltd
- Method for quantitatively analyzing fluorescent dyes labeled on extracellular vesicle by using fluorescence correlation spectroscopy, and use thereof24 Mar 2026US 12,584,794 B2The Asan Foundation
- Extracellular vesicle secretion reducing agent for reducing extracellular vesicle secretion, and use of the same3 Mar 2026US 12,565,654 B2THEORIA Science Inc.
- Compositions and methods for treatment24 Feb 2026US 12,558,350 B2Bausch + Lomb Ireland Limited
- Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the ifp35 family of proteins17 Sep 2026US 2026/0274909 A1Guangzhou Inno-Enmai Biomedical Technology Co., Ltd
- Compositions and methods for the identification of inhibitors of and treatment for ectopic calcification3 Sep 2026US 2026/0256761 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Humoral Immune Activators for the Treatment of Humoral Immunosuppressed Pathologies, Cancer and Infectious Disease and Humoral Immune Suppressors for the Treatment of Inflammatory Diseases3 Sep 2026US 2026/0256811 A1Navrogen, Inc.
- Lysine-free ubiquibody variants for long-lived intracellular protein silencing27 Aug 2026US 2026/0250647 A1
- Molecular probe functionalized element20 Aug 2026US 2026/0243761 A1
Most cited
By later US patents
- High throughput processing system and method of using171US 7,390,458 B2Irm LLC · 2008
- High affinity protein kinase inhibitors129US 6,383,790 B1Princeton University · 2002
- Antibodies associated with alterations in bone density88US 6,803,453 B1Darwin Discovery, Ltd. · 2004
- Compounds and methods for inhibiting .beta.-protein filament formation and neurotoxicity86US 5,780,587 APresident and Fellows of Harvard College · 1998
- Compositions and methods for treatment of eye disorders84US 8,168,655 B2Sarcode Bioscience Inc. · 2012